Harrow (HROW) Reports Q2 Loss, Tops Revenue Estimates
HROWHarrow Health(HROW) ZACKS·2024-08-08 06:35

Harrow (HROW) came out with a quarterly loss of 0.13pershareversustheZacksConsensusEstimateofalossof0.13 per share versus the Zacks Consensus Estimate of a loss of 0.25. This compares to loss of 0.02pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof480.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 48%. A quarter ago, it was expected that this pharmaceutical and drug compounding company would post a loss of 0.25 per share when it actually produced a loss of $0.28, delivering a surprise of -12%.Over the last four quarters, th ...